top of page
bg.png
logo.png

REGISTER

NOW!

JUNE 21 - 23, 2024

GRAND TRAVERSE RESORT & SPA TRAVERSE CITY, MI

The Michigan GI Society (MIGI) is excited to announce the 3rd Annual Michigan GI Society Conference, being held June 21-23, 2024, at the Grand Traverse Resort and Spa in Traverse City, MI!

MIGI is a professional organization providing education, support, and advocacy for healthcare providers in Michigan. The objective of the conference is to provide a comprehensive educational update highlighting data and information from the major annual US conferences in gastroenterology and liver disease to its healthcare provider members. The MIGI annual conference brings together gastroenterology providers including clinicians, researchers, advanced practice providers, and allied health professionals from Michigan.

Faculty

COURSE DIRECTORS

8b0a43_3eb9a74d2f61470b996fc92b96e7489b~mv2.png

Laith Jamil, MD, FASGE,

FACG, AGAF

Corewell Health

Royal Oak, MI

EvaNew.png

Eva Alsheik, MD

Henry Ford Health System

Detroit, MI

HouseOffcrsIntrnlMed18(294)_edited_edited.png

Jeffrey Berinstein, MD, MSc

Michigan Medicine

Ann Arbor, MI

Accreditation

Program Overview/Goal:

The conference will deliver focused, educational updates highlighting clinically relevant advances in the management of patients with CLD and GI disorders to attendees and will feature an interactive format designed to enhance the educational impact. Internationally renowned hepatologists and gastroenterologists will lead the development of educational content and will serve as program faculty. The faculty will review state of the art advances in CLD and GI disorders. The conference will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients.

Target Audience: 

The conference will target healthcare professionals, including gastroenterologists, nurse practitioners, and physician assistants.

 

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Describe current guidelines for the diagnosis and management of CLD and GI disorders.

  • Employ an evidence-based approach to the management of CLD and GI disorders.

  • Identify new advances presented at 2024 DDW and assess their potential impact on clinical practice.

Accreditation Statement: 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati College of Medicine (Cincinnati) and Professional Alliance for Continuing Education (PACE), in collaboration with Michigan Gastrointestinal Society (MIGI). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

University of Cincinnati College of Medicine estimates the educational activity for a maximum of

8.75 AMA PRA Category 1 Credits™.

MOC Designation:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Disclosure of Relevant Financial Relationships:

All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent relevant financial interests related to the content of the presentation or enduring material. Full disclosure of all financial relationships must be made in writing to the audience prior to the activity.

 

All additional planning committee members, the University of Cincinnati staff and the Professional Alliance for Continuing Education staff, have no relationships to disclose unless otherwise listed below.

 

Learner Assurance Statement:

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

 

Disclaimer:

The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.

 

Off-Label Disclosure Statement:

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

Fee Information
Visit https://www.migisocietymeeting.org/event-details/3rd-annual-michigan-gi-society-conference.

 

Jointly provided by the University of Cincinnati College of Medicine and the Professional Alliance for Continuing Education, in collaboration with Michigan Gastrointestinal Society.

Supported by an educational grant from Salix Pharmaceuticals and Janssen Biotech, Inc.,

administered by Janssen Scientific Affairs, LLC.

Cincinnati_Pace.png
Accreditation

CONTACT
US

Email: migi@pacemedcomm.com

MIGI
C/O Pace Medical Communications, Inc.
135 S State College Blvd. Suite 200
Brea, CA 92835

subscribe

Thanks for submitting!

bottom of page